Lightcalls.com
 

1 Omega-3s There's more evidence ...

1 Omega-3s

There's more evidence that consuming omega-3 fatty acids is well adapted for your heart.

Researchers in Finland followed 285 men and 130 women with coronary, heart disease. The volunteers' average age was 61

As the studious mood progressed, 36 participants died, 21 meet withed heart attacks and 12 had visitations But among all participants, those with the highest concentration of docosahexaenoic acid--an omega-3--showed a 69 percent lower risk of death than the bulk of mankind with the lowest levels.

Exactly in what way omega-3 fatty acids work is unclear. They may lower triglycerides in the life-current or they may make descendants platelets less likely to clot

Omega-3 sources include fatty fish, flaxseeds and flaxseed oil, olive oil and dietary supplements

The thought was published in the July 2003 issue of The American Journal of Clinical Nutrition.



2 Soy with Isoflavones

A secondary study published in that same issue of The American Journal of Clinical Nutrition conclud that "daily consumption of soy protein with isoflavones can outcome in positive vascular effects that are independent of lipid and antioxidant tenors in healthy postmenopausal women."

Researchers asked 28 women to devour 25 grams of three different protein fruitss for 6 weeks. The protein sources were soy with isoflavones; soy with small amounts of isoflavones; and milk, which had no isoflavones in it.

Soy with isoflavones significantly lowered brachial artery, run which is related to line pressure.

3 More Fiber

In a reflection of almost 10,000 people athwart 19 years, researchers found that dietary fiber, especially water-soluble fiber, reduc the risk of coronary heart disease.

application of mind participants who consumed an average of almost 21 grams of fiber by day were 12 percent les likely to make known heart disease than those with a cheap fiber intake.

What's more, fiber consumption has been linked to a reduction in colon cancer and cancer of the larynx.

The reflection was published in the September 8 2003 issue of the Archives of Internal Medicine.

COPYRIGHT 2004 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.